Evidence map›Paper›PMID 19650939›Full record

ArticleBMC cardiovascular disorders2009

Association between -T786C NOS3 polymorphism and resistant hypertension: a prospective cohort study.

Ignacio Cruz-González, Esther Corral, María Sánchez-Ledesma, Angel Sánchez-Rodríguez, Cándido Martín-Luengo, Rogelio González-Sarmiento

Open access · goldAbstract read
In one paragraph

Article in BMC cardiovascular disorders, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Cardiovascular Effects and Benefits of Exercise.Frontiers in cardiovascular medicine · 2018
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ignacio Cruz-GonzálezCardiology Department, University Hospital of Salamanca, Salamanca, Spain. cruzgonzalez.ignacio@gmail.com
Esther Corral
María Sánchez-Ledesma
Angel Sánchez-Rodríguez
Cándido Martín-Luengo
Rogelio González-Sarmiento
Universidad de Salamanca · ESCentro de Investigación del Cáncer · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is estimated that 5% of the hypertensive patients are resistant to conventional antihypertensive therapy. Polymorphisms in the endothelial nitric oxide synthase (NOS3) gene have been associated with high blood pressure levels, but not with resistant hypertension. The aim of the present study was to investigate if the -786T>C and G894T (Glu298Asp) polymorphisms of the NOS3 gene were associated with resistant hypertension.

methodsA prospective case-control observational study was performed. From a series of 950 consecutive patients followed up during 42 months, 48 patients with resistant hypertension were detected. 232 patients with controlled high blood pressure were also included.

resultsNo differences were observed in the distribution of G894T (Glu298Asp) NOS3 genotypes between the resistant hypertension group and the controlled hypertension patients. However, genotype -786CC was more frequent in the group of patients with resistant hypertension (33.3%) than in the group of patients with controlled high blood pressure (17.7%) (p 0.03). Furthermore carriers of allele T (-786TC and -786TT) were more frequent in patients with controlled hypertension (82.3%) than those with resistant hypertension (66.7%) (Multivariate analysis; RR 2.09; 95% CI 1.03-4.24; p 0.004).

conclusionOur results indicate that genotype -786CC of the NOS3 gene increase the susceptibility to suffer resistant hypertension, which suggest that resistance to conventional therapy could be determined at the endothelial level.

Indexed as

Polymorphism, GeneticAgedAged, 80 and overAntihypertensive AgentsBlood PressureCase-Control StudiesDrug ResistanceFemaleGene FrequencyGenetic Predisposition to DiseaseHumansHypertensionMaleMiddle AgedNitric Oxide Synthase Type IIIOdds RatioAntihypertensive AgentsNitric Oxide Synthase Type IIINOS3 protein, human

Identifiers

PMID19650939
PMCPMC2734743
OpenAlexW2147298738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.